The macrocyclic polyketides rapamycin and FK506 are potent immunosuppressants that prevent T-cell proliferation through specific binding to intracellular protein receptors (immunophilins). The cloning and specific alteration of the biosynthetic genes for these polyketides might allow the biosynthesis of clinically valuable analogues. We report here that three clustered polyketide synthase genes responsible for rapamycin biosynthesis in Streptomyces hygroscopicus together encode 14 homologous sets of enzyme activities (modules), each catalyzing a specific round of chain elongation. An adjacent gene encodes a pipecolate-incorporating enzyme, which completes the macrocycle. The total of 70 constituent active sites makes this the most complex multienzyme system identiried so far. The DNA region sequenced (107.3 kbp) contains 24 additional open reading frames, some of which code for proteins governing other key steps in rapamycin biosynthesis.
Polyketides are a large and highly diverse group of natural products that includes antibiotics, antitumor compounds, and immunosuppressants. The specific binding of polyketides to prevent T-cell proliferation was reported in 1992 by Schreiber (1) and Rosen and Schreiber (2) . These polyketide metabolites are produced by successive condensation of simple carboxylic acid units (primarily acetate and propionate) as for fatty acid biosynthesis (3) , except that the 3-keto function introduced during each elongation cycle may be reduced only partially or not at all. Macrocyclic polyketides are produced principally by Streptomyces and related filamentous bacteria, through the action of so-called type I modular polyketide synthases (PKSs), multienzymes in which different sets (modules) of enzymic activities catalyze each successive round of elongation, as first shown for the erythromycin-producing PKS (4) (5) (6) . Characterization and genetic engineering of such systems to produce "hybrid" products (7) are particularly challenging because of the large size of the genes and their products and because the factors that control the specificity of chain extension are still largely unknown (7, 8) .
Rapamycin ( Fig. 1 ) is a macrocyclic polyketide from Streptomyces hygroscopicus that, in addition to its antifungal (13) and antitumor (14) properties, is a potent immunosuppressant (15) . Like the structurally related FK506, rapamycin is of interest for the clinical treatment of autoimmune disease (16) and in the prevention of rejection of organ and skin allografts (15, 17) . In spite of their similar polyketide backbone, these immunosuppressants act in radically different ways on T cells, FK506 by inhibiting the production of interleukin 2 (1, 2) and rapamycin by preventing the proliferative response to interleukin 2 bound at the interleukin 2 receptor (18) . The engineered biosynthesis of altered rapamycins would also be of great interest for the study of these signaling processes. We have therefore undertaken a detailed study of the organization of the rapamycin biosynthetic genes in S. hygroscopicus.1
MATERIALS AND METHODS
Bacterial Strains and Cloning Vectors. S. hygroscopicus NRRL 5491 was used as the source of DNA in the construction of the genomic libraries. Escherichia coli strain NM538 was used as a host for AEMBL3, and E. coli strain XL1-Blue MR was used for pWE15 cosmid (Stratagene) recombinant derivatives. E. coli strain TG1 recO served as a host for plasmid subcloning in pUC118 and pUC18 (BRL).
DNA Procedures. Phage, cosmid, and plasmid preparations, DNA restriction digests, size fractionations, DNA-fragment isolations, ligation reactions, and gel electrophoresis were done by standard procedures (19) . E. coli transformation was done by following the procedure of Hanahan (20) . DNA templates for sequencing reactions were purified by Qiagen columns (Qiagen, Chatsworth, CA).
A library of size-fractionated genomic DNA in pUC18 was screened using probes derived from the eryA PKS genes from Saccharopolyspora erythraea (6) . A positive clone (pR19), containing both PKS and "late" genes, was used as the starting point for "chromosome walking." Phage and cosmid clones were obtained that provided multiple coverage over a contiguous 130-kb region of the S. hygroscopicus chromosome, and individual inserts were subcloned with plasmid vectors. Sequencing templates were obtained by random subcloning of fragments generated by controlled partial Hae III digestions.
DNA Sequencing and Analysis. Automated DNA sequencing was done on double-stranded DNA templates by the dideoxynucleotide chain-termination method (21) 1The sequence reported in this paper has been deposited in GenBank data base (accession no. X86780).
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Organization of the rapamycin biosynthetic gene cluster. The direction of transcription and relative sizes of the ORFs deduced from analysis of the nucleotide sequence are indicated. Letters under arrows relate to ORFs and rap gene products of Table 1 .
Protein Expression and Analysis. The pipecolate-incorporating enzyme was expressed in E. coli by using a pT7 expression system (26) and purified to homogeneity. The activity was measured by the method of Lee and Lipmann (27) .
RESULTS AND DISCUSSION
The rapamycin biosynthetic genes were identified by hybridization using DNA from the PKS genes of Saccharopolyspora erythraea that govern the biosynthesis of the macrocyclic polyketide antibiotic erythromycin A (4, 5). A total of 107.3 kbp of contiguous DNA was cloned and sequenced, and the deduced gene organization within this region is shown in Fig.  2 . The most striking feature is the presence of three extraordinarily large open reading frames (ORFs), rapA, rapB, and rapC. rapA, rapB, and rapC encode, respectively, the multienzymes Rapsl ("900 kDa), which contains the first four modules for polyketide chain extension; Raps2 ("1.07 MDa), which contains the next six modules containing the activities required to continue chain elongation up to C-16 (Fig. 1) ; and Raps3 (-660 kDa), which contains four modules required to complete the polyketide portion of the rapamycin ring (Table  1 ). In total, the three giant proteins contribute 70 catalytic functions, making this the largest and most complex multienzyme system identified so far. The integration of six modules within a single protein (Raps2) is also unprecedented. Previously studied modular PKSs possess either two modules per protein (4, 5) or up to three (28) . In modules three and six there are predicted active sites for reduction, which are not reflected in the ultimate structure of rapamycin and which may be nonfunctional (28) . It is possible that temporary reduction is necessary at C-26 and C-32 to provide conformational flexibility, so that the growing chain does not fold back on itself and inhibit further elongation.
Chain initiation on the rapamycin PKS may require an ATP-dependent carboxylic acid: CoA ligase. Such an activity was identified at the N terminus of Rapsl, adjacent to an enoyl reductase activity. The only precedent for such an adenylateforming domain is a sequence of unknown function from Bacillus subtilis (29) . Previous work (9, 10) has suggested that the substituted cyclohexanecarboxylic acid starter unit for the polyketide immunosuppressants is derived by reduction of shikimate, and our results indicate that at least one reductive step may occur after the CoA ligase has linked the starter unit to the Rapsl multienzyme.
The rapamycin PKS also has an unusual mechanism for chain termination and cyclization: embedded between the PKS genes and translationally coupled to rapC is a gene (rapP) with striking sequence similarity to activation domains of nonribosomal peptide synthetases (30) . rapP encodes a polypeptide of 170 kDa, which is exactly the size of the analogous enzyme purified from S. hygroscopicus var. ascomyceticus, which inserts pipecolic acid into the FK506 analogue immunomycin (31) . We propose that the polyketide chain of rapamycin is transferred from a thioester linkage on Raps3 directly to the amino group of an enzyme-bound pipecolyl moiety, which in turn is attacked by the C-34 hydroxyl group to form the macrolactam ring.
Lying to the right of the PKS genes in Fig. 2 are 13 other ORFs, for some of which there is significant sequence similarity with known proteins in published data bases. Several of the identifled genes can be plausibly assigned roles in rapamycin biosynthesis. The products of rapM and rapQ resemble methyltransferases (32, 33) and are presumably required for 0-methylation of hydroxyl groups on either C-39, C-27, or C-16. The clusters of both FK506 and immunomycin contain such methyltransferases (34) . Likewise, the gene products of rapJ and rapN resemble cytochrome P450 enzymes (35) and may hydroxylate C-9 and C-27 (and possibly also C-26 or C-32). The product of rapL shows significant sequence identity with ornithine cyclodeaminase (36) beyond ORF D has uncovered genes that appear to be required for cysteine biosynthesis, indicating the limit of the rapamycin cluster (A.K., T.S., J.F.A., and I.M., unpublished results).
On the left of the PKS genes in Fig. 2 are nine ORFs, for most of which no obvious function can be suggested. rapT, immediately downstream of rapB, encodes a discrete enzyme with significant sequence similarity to ketoreductases found in aromatic PKSs and fatty acid synthases. Beyond ORF Z lie genes that appear to be part of an operon for carbohydrate utilization, indicating the other probable limit of the rapamycin cluster (T.S., J.F.A., and I.M., unpublished results).
The cloned and sequenced DNA can be used for targeted gene disruption and the complementation of mutants, to provide final confirmation of the identity of the gene cluster, although the S. hygroscopicus strain has so far proved highly resistant to transformation. The evidence that the rapamycin gene cluster has indeed been cloned includes the following: (i) the presence of 14 modules of a type I PKS, as required for the addition of the seven acetate and seven propionate units of the rapamycin chain; (ii) the unconventional loading domain; (iii) the correct oxidation level predicted for 12 of the 14 modules, assuming a colinear arrangement of genes and activities as in the erythromycin-producing PKS (4, 5) ; and (iv) the lack of a gene encoding a conventional thioesterase off-loading domain. The latter is replaced in the cluster by the rapP gene, encoding an enzyme activating and incorporating pipecolic acid. To confirm the substrate specificity of the rapP gene product, the gene was overexpressed in E. coli and purified to homogeneity (unpublished work). The enzyme specifically catalyzed the L-pipecolic acid-stimulated exchange between pyrophosphate and ATP (A.K. and T.S., unpublished work), and it is therefore designated pipecolic acid-incorporating enzyme. The entirely analogous enzyme from S. hygroscopicus var. ascomyceticus has Proc. Natl. Acad. Sci. USA 92 (1995) Table 1. been convincingly linked to production of the FK506-analogous immunomycin (31) . The polyketide backbone of rapamycin and FK506 are identical in the region formed by rapC and its counterpart FKB-AIII apart from the degree of reduction at C-13 (hydroxyl group in FK506 vs. methylene in rapamycin). In agreement with this, rapC and FKB-AI house the same enzymic activities in the same order and differ only in the extra f3-hydroxyacyl-thioester dehydratase and enoyl reductase required to reduce the -OH group at C-13 to methylene in rapamycin. The apparent translational coupling of rapA and rapB and the very high sequence identity between rapamycin PKS modules suggest that the PKS genes for rapamycin and FK506 may have diverged from a common ancestor through recent recombination events. Finally, analysis of the sequences of the acyltransferase domains from each of the 14 modules and their comparison with the sequences (4, 5) of the methylmalonyl-CoA:ACP acyltransferases from the erythromycin-producing PKS reveal (Fig. 3) that the acyltransferase specificity of a module for an acetate or a propionate extender unit can be unambiguously predicted from its sequence (S.F.H., J.F.A., and I.M., unpublished work). The assignment of modules to condensation cycles made on the basis of the reductive activities present (Table 1) is in agreement with the deduced specificity of each acyltransferase in Fig. 3 .
The complete gene sequencing of a modular type I PKS for an immunosuppressant, together with most (if not all) of the other genes required for biosynthesis, is not only a prerequisite for engineering of such systems, it also promises further insight into the molecular signals that regulate the biosynthesis of a major class of antibiotics and other bioactive compounds. The sophistication of the enzymology involved also holds important lessons for our understanding of the natural evolution of biological catalysis.
